Heartflow (HTFL) EBITDA Margin (2024 - 2026)
Heartflow (HTFL) posted quarterly EBITDA Margin of 36.13% for Q4 2025, up 978.0% year-over-year from 3.35% in Q4 2024, and down 10.73% quarter-over-quarter from 32.63% in Q3 2025.
Heartflow (HTFL) EBITDA Margin (2024 - 2026) Analysis & Trends
Heartflow's EBITDA Margin history runs 2 years deep, the most recent figure standing at 36.13% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 978.0% year-over-year to 36.13%; the TTM figure through Dec 2025 stood at 36.03% (changed N/A YoY), while the FY2025 annual figure was 36.39%, up 1227.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 36.13%, down from 32.63% in the prior quarter.
- The five-year high for EBITDA Margin was 31.58% in Q2 2025, with the low at 45.91% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | 3.37% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | 29.03% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -12.95% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 19.00% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | 23.79% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 21.48% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | -27.93% |
| 10 | Privia Health | 2.78 Bn | 2.42 Bn | - | 1.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.93% |
| Dec 31, 2025 | -36.13% |
| Sep 30, 2025 | -32.63% |
| Jun 30, 2025 | -31.58% |
| Dec 31, 2024 | -45.91% |
| Sep 30, 2024 | -45.33% |
| Jun 30, 2024 | -45.65% |